财务数据和关键指标变化 - 公司在第三季度的收入为0.5百万美元,较去年同期有所增加,主要是由于有利的销售折扣和返利调整抵消了销售数量的下降 [6] - 销售成本略有下降至0.6百万美元,主要是由于与Sandoz的商业化协议延长导致无形资产摊销减少 [6] - 研发费用为7.4百万美元,较上年同期增加2.9百万美元,主要用于建立上市前商业供应、推进最近授权的L606临床项目以及支持人员增加 [6] - 管理费用为10.6百万美元,较上年同期增加3.9百万美元,主要由于与正在进行的诉讼相关的法律费用、为YUTREPIA潜在上市做准备的人员和商业费用以及股份支付费用增加 [6] - 公司在第三季度的净现金消耗为17.1百万美元,截至第三季度末现金余额为76.2百万美元 [6] 各条业务线数据和关键指标变化 - 公司的主要收入来自于treprostinil注射剂,该业务收入较去年同期有所增加 [6] - 公司正在开发的YUTREPIA和L606两个treprostinil吸入制剂项目进展顺利,YUTREPIA已在开放标签临床试验中显示出良好的耐受性和可滴定性,L606也在开放标签试验中显示出良好的安全性和有效性 [3][4] 各个市场数据和关键指标变化 - 公司认为PH-ILD市场的患者人群约为60,000人,这是一个巨大的未满足需求市场 [9][10] - 公司正在针对PAH和PH-ILD两个适应症积极准备YUTREPIA的商业化,并已建立了一支50人的销售团队,具有丰富的罕见病和肺动脉高压产品销售经验 [5][13] 公司战略和发展方向和行业竞争 - 公司认为YUTREPIA有望成为首选的prostacyclin治疗选择,其优势包括更好的耐受性、可滴定性和持久性 [17][18] - 公司正在与FDA讨论L606的注册路径,计划进行一项PH-ILD的III期临床试验,并利用开放标签试验的安全性数据支持PAH和PH-ILD的适应症 [13][14] - 公司正在应对United Therapeutics提起的专利诉讼,目前已获得PTAB裁定'793专利无效的有利决定,正在等待上诉结果 [3][4][19][25] 管理层对经营环境和未来前景的评论 - 公司对YUTREPIA和L606的临床和商业前景表示高度兴奋和乐观 [7][28] - 公司正做好充分准备,一旦获批将迅速进入市场,改变PAH治疗格局 [4][5] - 公司将继续保持谨慎的财务管理,同时把握法律和监管事件的发展机遇 [6]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal quarter ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39724 LIQUIDIA CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 85-1710962 (Stat ...

Liquidia Corporation (NASDAQ:LQDA) Q2 2023 Earnings Conference Call August 10, 2023 8:30 AM ET Company Participants Jason Adair - Chief Business Officer Roger Jeffs - Chief Executive Officer Rusty Schundler - General Counsel Mike Kaseta - Chief Financial Officer Rajeev Saggar - Chief Medical Officer Conference Call Participants Mary Kate - Bank of America Julian Harrison - BTIG Serge Belanger - Needham Kambiz Yazdi - Jefferies Matthew Kaplan - Ladenburg Thalmann Operator Good morning, and welcome everyone t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal quarter ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39724 LIQUIDIA CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 85-1710962 (State or ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal quarter ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39724 LIQUIDIA CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 85-1710962 (State or ...

Liquidia Corporation (NASDAQ:LQDA) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Jason Adair - SVP, Corporate Development and Strategy Roger Jeffs - CEO Michael Kaseta - CFO Rajeev Saggar - CMO Scott Moomaw - Chief Commercial Officer Rusty Schundler - General Counsel Conference Call Participants Greg Harrison - Bank of America Serge Belanger - Needham Julian Harrison - BTIG Kambiz Yazdi - Jefferies Matt Kaplan - Ladenburg Operator Good morning, and welcome, everyone, to the Liq ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39724 LIQUIDIA CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 85-1710962 (State or Other Jurisdi ...

Liquidia Corporation (NASDAQ:LQDA) Q4 2022 Earnings Conference Call March 16, 2023 8:30 AM ET Company Participants Jason Adair - SVP, Corporate Development and Strategy Roger Jeffs - CEO Rajeev Saggar - CMO Rusty Schundler - General Counsel Mike Kaseta - CFO Conference Call Participants Gregory Harrison - Bank of America Kambiz Yazdi - Jefferies Serge Belanger - Needham Julian Harrison - BTIG Matt Kaplan - Ladenburg Thalmann Operator Good morning, and welcome, everyone, to the Liquidia Corporation's Full Ye ...